The effect of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) as an adjuvant in patients with resectable pancreatic cancer

201636 citationsJournal Articlebronze Open Access

Authors

Antonios-Apostolos Tentes · Metropolitan Hospital

Konstantinos Stamou · Metropolitan Hospital

Nikolaos Pallas · Metropolitan Hospital

Christina Karamveri · Metropolitan Hospital

Dimitrios Kyziridis · Kyanous Stavros Hospital

Christos Hristakis · Kyanous Stavros Hospital

Abstract

It appears that HIPEC as an adjuvant following potentially curative resection (R<sub>0</sub>) of pancreatic carcinoma may effectively control the local-regional disease. Prospective randomised studies are required.

Topics & Keywords

Pancreatic and Hepatic Oncology Research Intraperitoneal and Appendiceal Malignancies Renal cell carcinoma treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: International Journal of Hyperthermia

Volume 32, Issue 8, pp. 895-899

DOI: 10.1080/02656736.2016.1227094

Field-Weighted Citation Impact: 1.54